Literature DB >> 27047227

NELL-1 expression in tumors of cartilage.

Jia Shen1, Gregory LaChaud2, Swati Shrestha1, Greg Asatrian1, Xinli Zhang3, Sarah M Dry4, Chia Soo5, Kang Ting3, Aaron W James6.   

Abstract

BACKGROUND/AIMS: NELL-1 is a novel osteochondral differentiation factor protein with increasing usage in tissue engineering. Previously, we reported the expression patterns of NELL-1 in bone-forming skeletal tumors. With increasing interest in the use of NELL-1 protein, we sought to examine the expression of NELL-1 in cartilage-forming tumors.
METHODS: Immunohistochemical expression was examined in human pathologic specimens.
RESULTS: Consistent NELL-1 overexpression across all cartilage-forming tumors was observed. Similar degrees of expression were observed in enchondroma, chondrosarcoma, and chondroblastic osteosarcoma. NELL-1 expression did not significantly vary by tumor grade.
CONCLUSION: In summary, NELL-1 demonstrates reliable and consistent expression across cartilage-forming skeletal tumors.

Entities:  

Keywords:  Chondroblastic osteosarcoma; Chondrosarcoma; Enchondroma; Nell-1; Osteosarcoma

Year:  2015        PMID: 27047227      PMCID: PMC4796526          DOI: 10.1016/j.jor.2015.10.001

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  28 in total

1.  Human NELL-1 expressed in unilateral coronal synostosis.

Authors:  K Ting; H Vastardis; J B Mulliken; C Soo; A Tieu; H Do; E Kwong; C N Bertolami; H Kawamoto; S Kuroda; M T Longaker
Journal:  J Bone Miner Res       Date:  1999-01       Impact factor: 6.741

Review 2.  Combination anabolic and antiresorptive therapy for osteoporosis.

Authors:  Natalie E Cusano; John P Bilezikian
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-19       Impact factor: 4.741

3.  Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.

Authors:  G E Friedlaender; C R Perry; J D Cole; S D Cook; G Cierny; G F Muschler; G A Zych; J H Calhoun; A J LaForte; S Yin
Journal:  J Bone Joint Surg Am       Date:  2001       Impact factor: 5.284

4.  A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.

Authors:  Yuriko Mori; Kun Cai; Yulan Cheng; Suna Wang; Bogdan Paun; James P Hamilton; Zhe Jin; Fumiaki Sato; Agnes T Berki; Takatsugu Kan; Tetsuo Ito; Carmit Mantzur; John M Abraham; Stephen J Meltzer
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

5.  NELL-1 based demineralized bone graft promotes rat spine fusion as compared to commercially available BMP-2 product.

Authors:  Wei Yuan; Aaron W James; Greg Asatrian; Jia Shen; Janette N Zara; Hai Jun Tian; Ronald K Siu; Xinli Zhang; Jeffrey C Wang; Jian Dong
Journal:  J Orthop Sci       Date:  2013-05-18       Impact factor: 1.601

6.  Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.

Authors:  John L Vahle; Masahiko Sato; Gerald G Long; Jamie K Young; Paul C Francis; Jeffery A Engelhardt; Michael S Westmore; Yanfei Linda; James B Nold
Journal:  Toxicol Pathol       Date:  2002 May-Jun       Impact factor: 1.902

7.  Prognostic significance of bone morphogenetic activity in osteosarcoma tissue.

Authors:  H Yoshikawa; K Takaoka; K Masuhara; K Ono; Y Sakamoto
Journal:  Cancer       Date:  1988-02-01       Impact factor: 6.860

Review 8.  Roles of bone morphogenetic protein signaling in osteosarcoma.

Authors:  Alan Nguyen; Michelle A Scott; Sarah M Dry; Aaron W James
Journal:  Int Orthop       Date:  2014-09-11       Impact factor: 3.075

9.  NELL-1-dependent mineralisation of Saos-2 human osteosarcoma cells is mediated via c-Jun N-terminal kinase pathway activation.

Authors:  Feng Chen; Ben Walder; Aaron W James; Donnalisa E Soofer; Chia Soo; Kang Ting; Xinli Zhang
Journal:  Int Orthop       Date:  2012-07-14       Impact factor: 3.075

10.  NELL-1 in the treatment of osteoporotic bone loss.

Authors:  Aaron W James; Jia Shen; Xinli Zhang; Greg Asatrian; Raghav Goyal; Jin H Kwak; Lin Jiang; Benjamin Bengs; Cymbeline T Culiat; A Simon Turner; Howard B Seim Iii; Benjamin M Wu; Karen Lyons; John S Adams; Kang Ting; Chia Soo
Journal:  Nat Commun       Date:  2015-06-17       Impact factor: 14.919

View more
  5 in total

1.  Nell-1 Is a Key Functional Modulator in Osteochondrogenesis and Beyond.

Authors:  C Li; X Zhang; Z Zheng; A Nguyen; K Ting; C Soo
Journal:  J Dent Res       Date:  2019-10-14       Impact factor: 6.116

2.  NELL-1 induces Sca-1+ mesenchymal progenitor cell expansion in models of bone maintenance and repair.

Authors:  Aaron W James; Jia Shen; Rebecca Tsuei; Alan Nguyen; Kevork Khadarian; Carolyn A Meyers; Hsin Chuan Pan; Weiming Li; Jin H Kwak; Greg Asatrian; Cymbeline T Culiat; Min Lee; Kang Ting; Xinli Zhang; Chia Soo
Journal:  JCI Insight       Date:  2017-06-15

3.  Age dependent effects of NELL-1 isoforms on bone marrow stromal cells.

Authors:  Carolyn A Meyers; Zhibo Sun; Leslie Chang; Catherine Ding; Amy Lu; Kang Ting; Shen Pang; Aaron W James
Journal:  J Orthop       Date:  2019-02-28

4.  Neural EGFL-Like 1 Is a Downstream Regulator of Runt-Related Transcription Factor 2 in Chondrogenic Differentiation and Maturation.

Authors:  Chenshuang Li; Jie Jiang; Zhong Zheng; Kevin S Lee; Yanheng Zhou; Eric Chen; Cymbeline T Culiat; Yiqiang Qiao; Xuepeng Chen; Kang Ting; Xinli Zhang; Chia Soo
Journal:  Am J Pathol       Date:  2017-03-14       Impact factor: 4.307

Review 5.  Biomarkers of chondrosarcoma.

Authors:  Wonju Jeong; Ha-Jeong Kim
Journal:  J Clin Pathol       Date:  2018-03-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.